Design Therapeutics, Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:DSGN) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 779.54 M
Employee 54
Founded 2017
CEO N/A
Website www.designtx.com
Headquarter Delaware, United States
FIGI BBG00SNC49V8
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

779.54 M Capitalizzazione di mercato

Notizie

Jefferies avvia la copertura su Design Therapeutics con buy sul potenziale del farmaco

Jefferies initiates Design Therapeutics stock with buy on drug potential

RBC Capital alza il target su Design Therapeutics sui programmi

RBC Capital raises Design Therapeutics stock price target on programs

Piper Sandler conferma rating Overweight su Design Therapeutics

Piper Sandler reiterates Overweight on Design Therapeutics stock

Oppenheimer promuove il titolo Compass Pathways a Outperform grazie al percorso FDA

Craig-Hallum avvia copertura su Design Therapeutics con rating Buy

Craig-Hallum initiates Design Therapeutics stock with Buy rating

Leerink Partners promuove Design Therapeutics a Outperform grazie ai progressi del pipeline

Leerink Partners upgrades Design Therapeutics stock to Outperform on pipeline progress

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday - Cipher Mining (NASDAQ:CIFR), Aduro Clean Technologies (NASDAQ:ADUR)